Preoperative immunotherapy for mesothelioma shows favorable outcomes
Researchers found that treating patients who have resectable malignant pleural mesothelioma, meaning that their tumor can be removed with surgery, with immunotherapy ahead of surgery resulted in favorable clinical outcomes.
Read Original Article: Preoperative immunotherapy for mesothelioma shows favorable outcomes »
